From the Department of Pediatric Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey.
Exp Clin Transplant. 2022 May;20(Suppl 3):118-121. doi: 10.6002/ect.PediatricSymp2022.O38.
Delayed graft function is a common adverse outcome after renal transplant. Attempts for early prediction and prevention of delayed graft function are often challenging and misleading. Herein, we investigated for the first time the correlation between delayed graft function and preoperative noninvasive hematologic parameters to predict the possible adverse outcomes for renal transplant in pediatric patients.
In this study, preoperative hematologic parameters of 51 pediatric renal transplant recipients followed between 2015 and 2021 were analyzed retrospectively. The selected 16 renal transplant patients with delayed graft function and 35 patients without delayed graft function had no concomitant comorbidities. The cutoff values for platelet-to-lymphocyte ratio of <5 and neutrophilto- lymphocyte ratio of <175 were considered low.
We retrospectively evaluated a total of 51 (male/female, 33/18) pediatric kidney transplant recipients with a median age of 12 (interquartile range, 8-18) years. Median level of circulating lymphocytes was significantly higher in patients with delayed graft function compared with patients without delayed graft function (2 vs 1, P = .040). The preoperative low values for platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio were more prevalent in recipients who developed delayed graft function versus those who did not develop delayed graft function (68.8% vs 31.4% [P = .014] and 68.8% vs 34.3% [P = .023], respectively).
Pretransplant low platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte were associated with increased number of delayed graft dysfunction. These novels and noninvasive inflammatory biomarkers may contribute to an early prediction of delayed graft function in pediatric kidney transplant recipients.
移植肾功能延迟恢复是肾移植后的常见不良后果。早期预测和预防移植肾功能延迟恢复往往具有挑战性且容易产生误导。在此,我们首次研究了移植肾功能延迟恢复与术前非侵入性血液学参数之间的相关性,以预测儿科患者肾移植的可能不良结局。
本研究回顾性分析了 2015 年至 2021 年间 51 例接受肾移植的儿科患者的术前血液学参数。选择 16 例移植肾功能延迟恢复的患者和 35 例无移植肾功能延迟恢复的患者作为对照,无其他合并症。血小板与淋巴细胞比值<5 和中性粒细胞与淋巴细胞比值<175 被认为是低值。
我们回顾性评估了 51 例(男/女,33/18)接受肾移植的儿科患者(中位年龄 12 岁,四分位距 8-18 岁)。与无移植肾功能延迟恢复的患者相比,移植肾功能延迟恢复的患者循环淋巴细胞水平明显更高(2 比 1,P =.040)。与无移植肾功能延迟恢复的患者相比,发生移植肾功能延迟恢复的患者术前血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值低值更为常见(68.8%比 31.4%,P =.014 和 68.8%比 34.3%,P =.023)。
移植前血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值低与移植肾功能延迟恢复的发生率增加相关。这些新颖的非侵入性炎症生物标志物可能有助于预测儿科肾移植受者的移植肾功能延迟恢复。